Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 53: 505-510, 2007. First published January 26, 2007; 10.1373/clinchem.2006.080051
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 080051.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2006.080051v1
53/3/505    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeurissen, A.
Right arrow Articles by Bossuyt, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeurissen, A.
Right arrow Articles by Bossuyt, X.
Related Collections
Right arrow Clinical Immunology
Right arrow Infectious Disease
(Clinical Chemistry. 2007;53:505-510.)
© 2007 American Association for Clinical Chemistry, Inc.

Clinical Immunology

Laboratory Diagnosis of Specific Antibody Deficiency to Pneumococcal Capsular Polysaccharide Antigens

Axel Jeurissen1,1, Leen Moens1,1, Marc Raes2, Greet Wuyts1, Luc Willebrords1, Kate Sauer2, Marijke Proesmans2, Jan L. Ceuppens3, Kris De Boeck2 and Xavier Bossuyt1,a

1 Laboratory Medicine, Immunology, University Hospital Leuven, Belgium.
2 Department of Pediatrics, University Hospital Leuven, Belgium.
3 Department of Internal Medicine, Allergy, University Hospital Leuven, Belgium.

aAddress correspondence to this author at: Laboratory Medicine, Immunology, GHB-Herestraat 49, B-3000 Leuven, Belgium. Fax 32-16-34-79-31; e-mail Xavier.bossuyt{at}uz.kuleuven.ac.be.

Background: Measurement of postimmunization antibody response to pneumococcal capsular polysaccharide (caps-PS) is the standard method to identify deficiency of antipolysaccharide antibody production. However, no standardized criteria have been defined for classification of patients into responders or nonresponders to caps-PS.

Methods: We vaccinated 37 healthy children and 39 healthy adults with Pneumovax® and measured the anti–caps-PS antibody response to 5 serotypes. We also measured antipneumococcal antibody titers in 82 patients with increased susceptibility to airway infection. The ELISA was performed according to the 3rd-generation assay format.

Results: The lower 5th percentile (cutoff) concentrations for the postimmunization antibody titer in healthy individuals were 0.67 mg/L, 0.45 mg/L, 0.46 mg/L, 0.31 mg/L, and 1.04 mg/L for serotypes 3, 4, 9N, 18C, and 19F, respectively. In 96% of healthy individuals, antibody responses higher than the cutoff concentration were seen for at least 3 of the 5 serotypes. Nine of 82 patients (11%) failed to mount an adequate antibody response for at least 4 of the 5 serotypes tested, whereas only 1 control (1.3%) failed to do so.

Conclusion: The cutoffs for antibody responses to caps-PS identified in this study appear useful for identifying individuals with an inadequate response to vaccine.




The following articles in journals at HighWire Press have cited this article:


Home page
 J. Immunol.Home page
L. Moens, M. Wuyts, I. Meyts, K. De Boeck, and X. Bossuyt
Human Memory B Lymphocyte Subsets Fulfill Distinct Roles in the Anti-Polysaccharide and Anti-Protein Immune Response
J. Immunol., October 15, 2008; 181(8): 5306 - 5312.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.